Advanced Search

NIAID > Topics > Antimicrobial (Drug) Resistance

Skip Website Tools

Website Tools

Skip Stay Connected

Stay Connected

Social media privacy policy and disclaimers.

Photo of Michael Otto, Ph.D. and Frank R. DeLeo, Ph.D.

Otherwise healthy people of all ages are at risk of acquiring staph infections that are easier than ever to obtain and harder and harder to stop. Find out how two NIAID scientists are fighting back.

Volunteer for NIAID-funded clinical studies related to antimicrobial (drug) resistance on ClinicalTrials.gov.

Featured Study

Why do certain people have recurrent or severe staph infections? Patients with staph infections can volunteer for a study to help investigators find out.

Javascript Error

Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on. Read more information on enabling JavaScript.

Antimicrobial (Drug) Resistance

Understanding Antimicrobial (Drug) Resistance
Definitions, Causes, Diagnosis, Treatment, and Prevention.
View the illustration:
"What is drug resistance?"

Examples of Antimicrobial (Drug) Resistance
Antibiotic-Resistant Mycobacterium tuberculosis (TB)
Methicillin-Resistant Staphylococcus aureus (MRSA)
Vancomycin-Resistant Enterococci (VRE)
Neisseria gonorrhoeae (Gonorrhea)

NIAID's Role in Addressing Antimicrobial (Drug) Resistance

The problem of antimicrobial (drug) resistance requires a multi-pronged research strategy. NIAID supports and conducts research on many aspects of antimicrobial (drug) resistance, from basic research on how microbes develop resistance to clinical trials that translate research from lab findings to potential treatments. NIAID works in concert with other federal agencies and partners with industry and nonprofit organizations to develop comprehensive programs aimed at controlling antimicrobial (drug) resistance.